Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 49

Sort by

Sort Order Select

Journal Articles

Fludarabine in Combination with Busulfan As Pretransplant Conditioning for Platelet Gene Therapy in Murine Hemophilia a with Inhibitors

Yingyu Chen, PhD, Jing Li, MD PhD, Jocelyn A. Schroeder, Weiqing Jing, MD PhD, Jianda Hu, PhD, Qizhen Shi, MD PhD

Blood (2019) 134 (Supplement_1): 1108.

https://doi.org/10.1182/blood-2019-127410

Published: 2019

Journal Articles

Evaluation of Biomarkers As Predictors of Blinatumomab Toxicity and Real-World Management of Blinatumomab Toxicity in B-Acute Lymphoblastic Leukemia Patients

Amber C. King, PharmD, BCOP, Jae H. Park, MD, Mark B. Geyer, MD

Blood (2019) 134 (Supplement_1): 3887.

https://doi.org/10.1182/blood-2019-128506

Published: 2019

Journal Articles

Acquired Dysfibrinogenemia Krakow III after Everolimus Therapy

Alona A. Merkulova, MA, Steven C. Mitchell, MA, Sergei Merkulov, PhD, Alisa S. Wolberg, PhD, Neerman-Arbez Marguerite, PhD, Alvin H. Schmaier, MD

Blood (2019) 134 (Supplement_1): 4934.

https://doi.org/10.1182/blood-2019-131319

Published: 2019

Journal Articles

Impact of Different Doses of Fludarabine in Fludarabine-Based Conditioning Regimen for Unrelated Bone Marrow Transplantation

Kodai Kuriyama, MD PhD, Shigeo Fuji, MD PhD, Noriko Doki, MD PhD, Yuta Katayama, MD PhD, Souichi Shiratori, Yukiyasu Ozawa, MD PhD, Takashi Ashida, MD PhD, Junya Kanda, MD, Takahiro Fukuda, Yoshiko Atsuta, MD PhD, Masao Ogata, MD PhD

Blood (2019) 134 (Supplement_1): 3258.

https://doi.org/10.1182/blood-2019-123926

Published: 2019

Journal Articles

Maximum Tolerated Dose Versus Fixed Low-Dose Hydroxyurea for Treatment of Adults with Sickle Cell Anemia - Retrospective Comparison of Two Studies

Titilola S. Akingbola, MBBS, FWACP, Bamidele Tayo, PhD, Chinedu A Ezekekwu, MBBS, Omowunmi Sonubi, MBBS, Santosh L. Saraf, MD, Lewis L. Hsu, Jin Han, PharmD, PhD, Richard S. Cooper, MD, Victor R. Gordeuk, MD

Blood (2018) 132 (Supplement 1): 3656.

https://doi.org/10.1182/blood-2018-99-114990

Published: 2018

Journal Articles

Reduced Intensity Conditioning (RIC) Regimens Hematopoietic Cell Transplantation (HCT) for Acute Myeloid Leukemia (AML): A Comparison of Fludarabine/Busulfan (FB) and Fludarabine/Melphalan (FM) Based Regimens from the CIBMTR

Rajneesh Nath, MD, Zheng Zhou, MD PhD, Jan Cerny, MD PhD, Hai-Lin Wang, MPH, Khalid Bo-Subait, Zartash Guth, Gulrayz Ahmed, Muhammad Wagas Khan, Gerhard Carl Hildebrandt, MD, Hassan B. Alkhateeb, MD, Moussab Damlaj, MD, Mrinal M. Patnaik, MD MBBS, Brenda M. Sandmaier, MD, Daniel J. Weisdorf, MD, Marcos de Lima, MD, Mark R. Litzow, MD, Wael Saber, MD MS

Blood (2018) 132 (Supplement 1): 3456.

https://doi.org/10.1182/blood-2018-99-116795

Published: 2018

Journal Articles

Low Fixed Dose Hydroxyurea for the Treatment of Adults with Sickle Cell Disease in Nigeria

Titilola S. Akingbola, MBBS, FWACP, Bamidele Tayo, PhD, Santosh L. Saraf, MD, Binal N. Shah, PhD, Chinedu A Ezekekwu, MBBS, Omowunmi Sonubi, MBBS, Lewis L. Hsu, MD PhD, Richard S. Cooper, MD, Victor R. Gordeuk, MD

Blood (2017) 130 (Supplement 1): 981.

https://doi.org/10.1182/blood.V130.Suppl_1.981.981

Published: 2017

Journal Articles

Impact of the Type of Anthracycline and of Allogeneic Stem Cell Transplantation in the Treatment of Younger Acute Myeloid Leukemia Patients: Long-Term Follow-up of the EORTC-Gimema AML-10 Trial

Blood (2017) 130 (Supplement 1): 3850.

https://doi.org/10.1182/blood.V130.Suppl_1.3850.3850

Published: 2017

Journal Articles

Low Dose Donor Lymphocyte Infusion (DLI) Is Effective As Prophylactic Therapy for Mixed Chimerism in the Setting of In-Vivo T Cell Depleted Allogeneic Hematopoietic Cell Transplantation

Dinesh Atwal, MD, Krishna Joshi, MD, Anusha Jillela, MD, Pooja Motwani, MD, Appalanaidu Sasapu, MD, Muthu Veeraputhiran, MD

Blood (2017) 130 (Supplement 1): 5507.

https://doi.org/10.1182/blood.V130.Suppl_1.5507.5507

Published: 2017

Journal Articles

Evaluation of the Hemostatic Profile in Mice with Chronic Liver Disease: Effects of Protein S and Combined Gas6 and Protein S Deficiencies

Sara Calzavarini, PhD, Natacha Dewarrat, Jovana Jankovic, Claudia Quarroz, Maria Desiré Reina Caro, Raja Prince, Andrea de Gottardi, Anne Angelillo-Scherrer

Blood (2017) 130 (Supplement 1): 1097.

https://doi.org/10.1182/blood.V130.Suppl_1.1097.1097

Published: 2017

Journal Articles

Comparable Outcomes after Allogeneic Stem-Cell Transplantation with Intravenous Busulfan or Treosulfan-Based Reduced-Intensity and Reduced Toxicity Regimens in Acute Myeloid Leukemia. a Study on Behalf of the Acute Leukemia Working Party of EBMT

Avichai Shimoni, MD, Myriam Labopin, Bipin N. Savani, MD, Rose-Marie Hamladji, Dietrich W. Beelen, Prof. Dr. MD, Ghulam J. Mufti, DM, FRCP, FRCPath, Gerard Socié, MD PhD, Jeremy Delage, MD, Didier Blaise, MD PhD, Patrice Chevallier, MD PhD, Noel Milpied, MD PhD, Eric Deconinck, MD PhD, Mohamad Mohty, MD PhD, Arnon Nagler

Blood (2016) 128 (22): 2280.

https://doi.org/10.1182/blood.V128.22.2280.2280

Published: 2016

Journal Articles

Comparison of Reduced-Intensity Conditioning with Fludarabine/Busulfan and Fludarabine/Melphalan in Patients 50 Years or Older

Koji Kawamura, MD, Shinichi Kako, MD, Shuichi Mizuta, MD PhD, Ken Ishiyama, MD PhD, Jun Aoki, MD, Shingo Yano, MD PhD, Takahiro Fukuda, MD, Naoyuki Uchida, MD PhD, Yukiyasu Ozawa, MD PhD, Tetsuya Eto, MD PhD, Koji Iwato, MD, Tatsuo Ichinohe, MD PhD, Yoshiko Atsuta, MD PhD, Yoshinobu Kanda, MD PhD

Blood (2016) 128 (22): 3414.

https://doi.org/10.1182/blood.V128.22.3414.3414

Published: 2016

Journal Articles

Inhibition of Alternative Complement Pathway in Target Organs Represents a Novel and Effective Approach to Control Gvhd While Sparing GVL Effect

Hung D Nguyen, PhD, Ali Alawieh, MD PhDCandidate, David A Bastian, BS, Anusara Daenthanasanmak, PhD, Steven D Schutt, BS, Supinya Iamsawat, MSc, Yongxia Wu, PhD, Atkinson Carl, PhD, Stephen Tomlinson, PhD, Xue-Zhong Yu, PhD

Blood (2016) 128 (22): 807.

https://doi.org/10.1182/blood.V128.22.807.807

Published: 2016

Journal Articles

Impact of Induction Regimen and of Allogeneic Hematopoietic Cell Transplantation on the Outcome in Younger Adults Patients with Acute Myeloid Leukemia with a Monosomal Karyotype: Results from the EORTC/Gimema AML-10 and AML-12 Trials

Frederic Baron, MD PhD, Marian Stevens-Kroef, PhD, Giovanna Meloni, MD, Petra Muus, MD PhD, Jean-Pierre Marie, MD, Constantijn J.M. Halkes, MD PhD, Xavier Thomas, MD PhD, Radovan Vrhovac, MD PhD, Giorgina Specchia, MD, Francois Lefrere, Sr., MD, Simona Sica, Marco Mancini, MD, Adriano Venditti, MD, Anne Hagemeijer, MD, Joop H. Jansen, PhD, Sergio Amadori, MD, Theo de Witte, MD, Roelof Willemze, MD PhD, Stefan Suciu, PhD

Blood (2016) 128 (22): 2847.

https://doi.org/10.1182/blood.V128.22.2847.2847

Published: 2016

Journal Articles

Fludarabine Busulfan Compared to Fludarabine Melphalan Is Associated with Increased Relapse Risk in Reduced Intensity Conditioning Transplant Despite Pharmacokinetic Dosing

Moussab Damlaj, MD, Hassan B Alkhateeb, MD, Daniel K. Partain, MD, Jehad Almasri, MD, Mehrdad Hefazi, MD, Shahrukh K. Hashmi, MD, Dennis A. Gastineau, MD, Aref Al-Kali, MD, Robert C Wolf, PharmD, Naseema Gangat, MBBS, Mark R Litzow, MD, William J Hogan, MBChB, Mrinal M Patnaik, MBBS

Blood (2015) 126 (23): 736.

https://doi.org/10.1182/blood.V126.23.736.736

Published: 2015

Journal Articles

Similar Outcomes of Allogeneic Hematopoietic Cell Transplantation from Matched Sibling Donor and Haploidentical Donor for Refractory/Relapsed Acute Myeloid Leukemia

Dai-Hong Liu, Li Yu, Wenrong Huang, Liping Dou, Honghua Li, Gao Chunji, Bo Jian, Fei Li, Lili Wang

Blood (2015) 126 (23): 5511.

https://doi.org/10.1182/blood.V126.23.5511.5511

Published: 2015

Journal Articles

More Efficient Generation of β-Globin-Expressing Erythroid Cells Using Stromal Cell-Derived Induced Pluripotent Stem Cells

Naoya Uchida, Fujita Atsushi, Haro-Mora J Juan, Thomas Winkler, MD, John F Tisdale, MD

Blood (2015) 126 (23): 1150.

https://doi.org/10.1182/blood.V126.23.1150.1150

Published: 2015

Journal Articles

Early T-Lymphocyte Chimerism Kinetics Is Influenced By Conditioning Regimen in Reduced Intensity Allogeneic Stem Cell Transplantation

Nosha Farhadfar, MD, Damlaj Moussab, MD, Ajoy L. Dias, MD, Hassan B Alkhateeb, MD, Mark R Litzow, MD, Shahrukh K. Hashmi, MD, Mrinal M Patnaik, MBBS, William J Hogan, MBChB

Blood (2015) 126 (23): 1923.

https://doi.org/10.1182/blood.V126.23.1923.1923

Published: 2015

Journal Articles

Similar Incidence of Severe Acute Gvhd and Less Extensive Chronic Gvhd in PBSCT from Unmanipulated Haploidentical Donor Compared with That from Matched Sibling Donor for Patients with Hematologic Malignancies

Honghua Li, Wenrong Huang, Chunji Gao, Liping Dou, Fei Li, Quanshun Wang, Lili Wang, Li Yu, Dai-Hong Liu

Blood (2015) 126 (23): 1964.

https://doi.org/10.1182/blood.V126.23.1964.1964

Published: 2015

Journal Articles

Clofarabine in Combination with a Standard Remission Induction Regimen in Patients 18-60 Years Old with Previously Untreated Intermediate and Bad Risk Acute Myelogenous Leukemia (AML) or High Risk Myelodysplasia (MDS): Combined Phase I/II Results of the EORTC/Gimema AML-14A Trial

Dominik L.D. Selleslag, MD, Stefan Suciu, Giovanna Meloni, MD, Petra Muus, MD PhD, Constantijn J.M. Halkes, MD PhD, Adriano Venditti, MD, Safaa M Ramadan, MD PhD, Hans Pruijt, MD PhD, Liv Meert, MSc, Marco Vignetti, MD, Jean-Pierre Marie, MD, Dominique Bron, MD PhD, Theo de Witte, MD, Sergio Amadori, MD, Roelof Willemze, MD PhD, Frederic Baron, MD PhD

Blood (2014) 124 (21): 3675.

https://doi.org/10.1182/blood.V124.21.3675.3675

Published: 2014

NARROW

Fludarabine in Combination with Busulfan As Pretransplant Conditioning for Platelet Gene Therapy in Murine Hemophilia a with Inhibitors

Evaluation of Biomarkers As Predictors of Blinatumomab Toxicity and Real-World Management of Blinatumomab Toxicity in B-Acute Lymphoblastic Leukemia Patients

Acquired Dysfibrinogenemia Krakow III after Everolimus Therapy

Impact of Different Doses of Fludarabine in Fludarabine-Based Conditioning Regimen for Unrelated Bone Marrow Transplantation

Maximum Tolerated Dose Versus Fixed Low-Dose Hydroxyurea for Treatment of Adults with Sickle Cell Anemia - Retrospective Comparison of Two Studies

Reduced Intensity Conditioning (RIC) Regimens Hematopoietic Cell Transplantation (HCT) for Acute Myeloid Leukemia (AML): A Comparison of Fludarabine/Busulfan (FB) and Fludarabine/Melphalan (FM) Based Regimens from the CIBMTR

Low Fixed Dose Hydroxyurea for the Treatment of Adults with Sickle Cell Disease in Nigeria

Impact of the Type of Anthracycline and of Allogeneic Stem Cell Transplantation in the Treatment of Younger Acute Myeloid Leukemia Patients: Long-Term Follow-up of the EORTC-Gimema AML-10 Trial

Low Dose Donor Lymphocyte Infusion (DLI) Is Effective As Prophylactic Therapy for Mixed Chimerism in the Setting of In-Vivo T Cell Depleted Allogeneic Hematopoietic Cell Transplantation

Evaluation of the Hemostatic Profile in Mice with Chronic Liver Disease: Effects of Protein S and Combined Gas6 and Protein S Deficiencies

Comparable Outcomes after Allogeneic Stem-Cell Transplantation with Intravenous Busulfan or Treosulfan-Based Reduced-Intensity and Reduced Toxicity Regimens in Acute Myeloid Leukemia. a Study on Behalf of the Acute Leukemia Working Party of EBMT

Comparison of Reduced-Intensity Conditioning with Fludarabine/Busulfan and Fludarabine/Melphalan in Patients 50 Years or Older

Inhibition of Alternative Complement Pathway in Target Organs Represents a Novel and Effective Approach to Control Gvhd While Sparing GVL Effect

Impact of Induction Regimen and of Allogeneic Hematopoietic Cell Transplantation on the Outcome in Younger Adults Patients with Acute Myeloid Leukemia with a Monosomal Karyotype: Results from the EORTC/Gimema AML-10 and AML-12 Trials

Fludarabine Busulfan Compared to Fludarabine Melphalan Is Associated with Increased Relapse Risk in Reduced Intensity Conditioning Transplant Despite Pharmacokinetic Dosing

Similar Outcomes of Allogeneic Hematopoietic Cell Transplantation from Matched Sibling Donor and Haploidentical Donor for Refractory/Relapsed Acute Myeloid Leukemia

More Efficient Generation of β-Globin-Expressing Erythroid Cells Using Stromal Cell-Derived Induced Pluripotent Stem Cells

Early T-Lymphocyte Chimerism Kinetics Is Influenced By Conditioning Regimen in Reduced Intensity Allogeneic Stem Cell Transplantation

Similar Incidence of Severe Acute Gvhd and Less Extensive Chronic Gvhd in PBSCT from Unmanipulated Haploidentical Donor Compared with That from Matched Sibling Donor for Patients with Hematologic Malignancies

Clofarabine in Combination with a Standard Remission Induction Regimen in Patients 18-60 Years Old with Previously Untreated Intermediate and Bad Risk Acute Myelogenous Leukemia (AML) or High Risk Myelodysplasia (MDS): Combined Phase I/II Results of the EORTC/Gimema AML-14A Trial

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only